Results 101 to 110 of about 38,934 (294)

Pheochromocytoma Masquerading as “Diabetic Ketoacidosis”

, 2016
Diabetic ketoacidosis is a routinely encountered diagnosis in medicine. Physicians are trained early on to look for precipitants. Most clinicians assess for medication compliance, infection, ischemia, and the like.
Maria Nien-Feng Lee MD, Jeffrey Stephen Hedley MD, Rebecca D. Levit MD, Adriana Ioachimescu MD, Sidney Law MD, Sujoy Phookan MD   +5 more
core   +1 more source

Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims This Phase 1b, randomised, double‐blind clinical trial investigated the contribution of glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) to insulin sensitivity and secretion in people with type 2 diabetes (T2D) on metformin. Materials and Methods Participants were randomised to receive the long‐acting
Tim Heise, Eric Zijlstra, Andrea Mari, William C. Roell, Kieren J. Mather, Axel Haupt, Panagiotis Flevaris, Ran Liao, Laiyi Chua, Charles Harris, Edward J. Pratt   +10 more
wiley   +1 more source

Diabetic ketoacidosis complicating pregnancy.

, 1996
OBJECTIVE: This report describes the physiologic alterations that predispose pregnant women to diabetic ketoacidosis and the experience in a tertiary center after adoption of aggressive management of diabetics. STUDY DESIGN: In 1982 a protocol for strict
McLaughlin, B N, Morrison, J C, Roberts, W E, Sullivan, C A, Chauhan, S P, Perry, K G   +5 more
core  

Randomised Controlled Multicentre Trial to Investigate the Effectiveness of a Mobile Artificial Intelligence Solution for Diabetes Adapted Care: The MELISSA Trial Protocol

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Achieving optimal glycaemic control remains a burden for many people with diabetes on intensive insulin treatment. The MELISSA trial aims to clinically validate the artificial intelligence (AI)‐based MELISSA system to support people with Type 1 diabetes on multiple daily insulin injections (MDI) with personalised insulin dose ...
Elisabeth J. den Brok, Cecilie H. Svensson, Mikkel T. Olsen, Nefeli M. Dimitropoulou, Sander M. J. van Kuijk, Maria Panagiotou, Lubnaa Abdur Rahman, Stephan Proennecke, Peter R. Mertens, Stavros Athanasopoulos, Cassy F. Dingena, Konstantinos Makrilakis, Stavroula Mougiakakou, Ulrik Pedersen‐Bjergaard, Bastiaan E. de Galan, on behalf of the MELISSA consortium   +15 more
wiley   +1 more source

Diabetic ketoacidosis knowledge in type 1 diabetes: a Brazilian perspective

Archives of Endocrinology and Metabolism
Objective: To evaluate the factors associated with knowledge of diabetic ketoacidosis among individuals with type 1 diabetes mellitus and to analyze how sociodemographic, clinical, and healthcare access variables influence understanding of the condition ...
Renan Bruno Faria Pisani, Virgínia Valiate Gonzalez, Bruna Rambo Witte, Taylane Guimarães Gonçalves, Lohane Alves Santiago, Adalgiza Mafra Moreno, Rodrigo de Azeredo Siqueira   +6 more
doaj   +1 more source

Frequency of Diabetic Ketoacidosis and Severe Hypoglycemia in Children with Type 1 Diabetes

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2022
Background and Objective: Diabetic ketoacidosis and severe hypoglycemia are common and recurrent acute complications of type 1 diabetes and are associated with high mortality and morbidity. The aim of this study was to determine the frequency of diabetic
A Homaei, F Saffari, E Parsarad, ZS Mohammadi   +3 more
doaj  

Boerhaave syndrome in a paediatric patient with diabetic ketoacidosis: A case report [PDF]

Scripta Medica
Diabetic ketoacidosis is a serious and potentially life-threatening complication of type 1 diabetes mellitus (T1DM), which often results from poor glycaemic control.
Alkhalifah Yasir S.
doaj   +1 more source

Adults diabetic ketoacidosis.

, 2021
Diabetic ketoacidosis (DKA) is one of the most common complications of hyperglycemia with the highest risk of death in diabetic patients. This disease is characterized by hyperglycemia, metabolic acidosis and ketosis.
Kaušaitė, Dominyka,, Masys, Šarūnas,
core  

Impact of Removing Restrictive Haemoglobin A1C Eligibility Criteria for Insulin Pump Therapy Funding for Children With Type 1 Diabetes in Ontario, Canada

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims In Ontario, publicly funded insulin pump therapy has been available to children with Type 1 diabetes since 2006. Before 31 March 2022, eligibility required three Haemoglobin A1c (A1C) measurements in the preceding year, with the two most recent < 10%. On 1 April 2022, this criterion was removed.
Alanna Weisman, Karl Everett, Peter C. Austin, Rayzel Shulman   +3 more
wiley   +1 more source

Diabetic Ketoacidosis: A Review and Update

, 2013
Diabetic ketoacidosis (DKA) remains a significant complication of diabetes in both the United States and around the world. Diabetic ketoacidosis remains a significant complication of diabetes in both the United States and worldwide with its associated ...
Ahmad, Aakif N, DO, Saraceni, Christine, Perilli, Gretchen, MD, Daniels, Michael N, DO   +3 more
core   +1 more source